logo
info@seolistinghub.com
Email Us

FDA Approves AstraZeneca’s IMFINZI® (durvalumab) Plus Chemotherapy to Treat Severe Types of Endometrial Cancer

FDA Approves AstraZeneca’s IMFINZI® (durvalumab) Plus Chemotherapy to Treat Severe Types of Endometrial Cancer

AstraZeneca’s IMFINZI® (durvalumab) plus chemotherapy has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients struggling with mismatch repair deficient (dMMR) advanced or recurrent endometrial cancer. According to the company’s announcement on Monday, June 18, its latest therapy, IMFINZI® (durvalumab), combined with paclitaxel and carboplatin, followed by the latest IMFINZI monotherapy, have been approved based on prespecified exploratory subgroup results analysis in the DUO-E Phase III.

Please login to comment on this Post

Most Visited Posts

1

Electric pressure cleaner

At Jet Blaster, we offer a ton of options if you're looking for a pressure washer or pressure cleaner that can help you with your operations. Visit our website today and grab the best deals on electric pressure washer and electric pressure cleaner.  

2

Legal Guidelines for Tattoo Studios in Kolkata

Tattoo Studio in Kolkata | 3 Cube Tattoo...

3

Medical Coding Courses in Russia

  Discover affordable...

4

ACS RPL Australia | ACS Australia Writing Services

CDRAustralia.Org offers top-notch services for...

5

Explore the Best British Restaurants in Dubai!

Hey there! Are you a food enthusiast looking to...

6

Bridging Futures: Leading BA Colleges in Arunachal Pradesh

Embark on a transformative academic adventure at...

7

Wholesale Disposable Vapes in the USA: Buy in Bulk from KangerWholesaleUSA

In the fast-growing vaping industry, businesses...

8

Building Your Own Rental Business with an Airbnb Clone App

Remember 2008? Two guys with a spare room and a...

9

Affordable Kitchen Remodeling with Jerong Products

Jerong Products provides an excellent solution...

10

Best Orthopedic Surgeon in Ahemdabad Gujrat

Experience top-notch care with our best...

Follow Us on